Evidence map›Paper›PMID 34381536›Full record

ArticleThe Pan African medical journal2021

Reactive mass vaccination campaign against cholera in the COVID-19 context in Cameroon: challenges, best practices and lessons learned.

Adidja Amani, André Arsène Bita Fouda, Armanda Jeanne Nangmo, Solange Ngo Bama, Collins Asaah Tatang, Marie Angèle Mbang, Emmanuel Christian Epee Douba, Aimé Gilbert Mbonda Noula, Mariette Dia, Malika Bouhenia

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Frontiers in medicine · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Adidja AmaniSub-Directorate of Vaccination, Directorate of Family Health, Ministry of Public Health, Yaoundé, Cameroon.
André Arsène Bita FoudaWorld Health Organization, Regional Office for Africa, Vaccine-Preventable Disease Unit, Brazzaville, Republic of Congo.
Armanda Jeanne NangmoEvodoula District Hospital, Evodoula, Cameroon.
Solange Ngo BamaMuea Medicalized Center, Buea, Cameroon.
Collins Asaah TatangSub-Directorate of Vaccination, Directorate of Family Health, Ministry of Public Health, Yaoundé, Cameroon.
Marie Angèle MbangSub-Directorate of Vaccination, Directorate of Family Health, Ministry of Public Health, Yaoundé, Cameroon.
Emmanuel Christian Epee DoubaNational Operating Office, Disease Prevention and Control Office, Emergency Preparedness and Control Office, World Health Organization Country Office, Yaoundé, Cameroon.
Aimé Gilbert Mbonda NoulaCommunity Epidemic and Pandemic Preparedness, International Federation of Red Cross and Red Crescent Societies Cluster Support Team, Central Africa Region, Yaoundé, Cameroon.
Mariette DiaWorld Health Organization Africa Office, Brazzaville, Republic of Congo.
Malika BouheniaWorld Health Organization Main Office, Geneva, Switzerland.
Ministry of Public Health · CMWorld Health Organization Regional Office for Africa · CGInternational Federation of Red Cross and Red Crescent Societies · CHOffice of Disease Prevention · USUniversity of Buea · CMWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionsince 1971, Cameroon is facing a growing series of cholera epidemics despite all the efforts made by the government to address this huge public health threat. In 2020, in addition to the COVID-19 pandemic, Cameroon recorded a high cholera case fatality rate of 4.3% following epidemics noted in the South, Littoral and South-West regions. The Cameroon Ministry of Public Health, has thus organized a reactive vaccination campaign against cholera to address the high mortality rate in the affected health districts of those regions. The objective of this study was to describe the challenges, best practices and lessons learned drawing from daily experiences from this reactive vaccination campaign against cholera.

methodswe conducted a cross-sectional study drawn from the results of the campaign. We had a target population of 631,109 participants aged 1 year and above resident of the targeted health areas.

resultsthe overall vaccination coverage was 64.4% with a refusal rate ranging from 0-10% according to health districts. Vaccination coverage was the lowest among people aged 20 years and above. The main challenge was difficulty maintaining physical distanciation, the main best practice was the screening of all actors taking part at the vaccination against COVID-19 and we found that emphasizing on thorough population sensitization through quarter heads and social mobilizers and adequately programming the campaign during a good climate season is crucial to achieving good vaccination coverage.

conclusionlessons learned from this study could serve to inform various agencies in the event of planning rapid mass vaccination programs during pandemics.

Indexed as

COVID-19AdolescentAdultAgedAged, 80 and overCameroonCholeraCholera VaccinesCross-Sectional StudiesFemaleHumansMaleMass VaccinationMiddle AgedPublic HealthVaccinationCholera VaccinesCameroonChallengescholeraCOVID-19lessons learnedpracticesvaccination

Identifiers

PMID34381536
PMCPMC8325454
OpenAlexW3159050326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.